TB, or not TB: that is the question - does TLR signaling hold the answer?

被引:48
作者
Doherty, TM
Arditi, M
机构
[1] Cedars Sinai Med Ctr, Dept Pediat Infect Dis & Immunol, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Atherosclerosis Res Ctr, Div Cardiol, Los Angeles, CA 90048 USA
关键词
D O I
10.1172/JCI200423867
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Innate immunity critically depends on signaling by Toll-like receptors (TLRs) that rely heavily on an intracellular adapter protein called myeloid differentiation factor 88 (MyD88). Adaptive immune defenses are generally thought to be orchestrated by innate immune responses and so should require intact TLR-MyD88 signaling pathways. But a surprising new study in MyD88-null mice infected with Mycobacterium tuberculosis challenges this view and instead suggests that MyD88 may not be absolutely required for a normal adaptive immune response (see the related article beginning on page 1790).
引用
收藏
页码:1699 / 1703
页数:5
相关论文
共 34 条
[31]   Cutting edge:: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection [J].
Takeuchi, O ;
Hoshino, K ;
Akira, S .
JOURNAL OF IMMUNOLOGY, 2000, 165 (10) :5392-5396
[32]   Innate immunity to Mycobacterium tuberculosis [J].
van Crevel, R ;
Ottenhoff, THM ;
van der Meer, JWM .
CLINICAL MICROBIOLOGY REVIEWS, 2002, 15 (02) :294-+
[33]   Cutting edge:: Protective cell-mediated immunity to Listeria monocytogenes in the absence of myeloid differentiation factor 88 [J].
Way, SS ;
Kollmann, TR ;
Hajjar, AM ;
Wilson, CB .
JOURNAL OF IMMUNOLOGY, 2003, 171 (02) :533-537
[34]  
*WHO, 2004, 104 WHO